Unknown

Dataset Information

0

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.


ABSTRACT: RSV is divided into two antigenic subtypes, RSV A and RSV B, which is largely based on the variation in the G protein, while the fusion protein F is more conserved and a target for antibody-mediated neutralization. Here we evaluate the breadth of the protective immune responses across RSV A and RSV B subtypes, induced by vaccines based on the RSV A-based fusion protein, stabilized in the prefusion conformation (preF) in preclinical models. Immunization of naïve cotton rats with preF subunit or preF encoded by a replication incompetent Adenoviral 26, induced antibodies capable of neutralizing recent RSV A and RSV B clinical isolates, as well as protective efficacy against a challenge with RSV A and RSV B strains. Similarly, induction of cross-neutralizing antibodies was observed after immunization with Ad26-encoded preF, preF protein or a mix of both (Ad26/preF protein) in RSV pre-exposed mice and African Green Monkeys. Transfer of serum of human subjects immunized with Ad26/preF protein into cotton rats provide protection against challenges with both RSV A and RSV B, with complete protection against both strains observed in the lower respiratory tract. In contrast, almost no protection against RSV A and B infection was observed after the transfer of a human serum pool isolated pre-vaccination. These results collectively show that the RSV A-based monovalent Ad26/preF protein vaccine induced neutralizing antibodies, as well as protection against both RSV A and RSV B subtypes in animals, including by passive transfer of human antibodies alone, suggesting that clinical efficacy against both subtypes can be achieved.

SUBMITTER: Cox F 

PROVIDER: S-EPMC10057437 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.

Cox Freek F   Saeland Eirikur E   Thoma Anne A   van den Hoogen Ward W   Tettero Lisanne L   Drijver Joke J   Vaneman Cornelis C   van Polanen Yolinda Y   Ritschel Tina T   Bastian Arangassery Rosemary AR   Callendret Benoit B   Zahn Roland R   van der Fits Leslie L  

Vaccines 20230316 3


RSV is divided into two antigenic subtypes, RSV A and RSV B, which is largely based on the variation in the G protein, while the fusion protein F is more conserved and a target for antibody-mediated neutralization. Here we evaluate the breadth of the protective immune responses across RSV A and RSV B subtypes, induced by vaccines based on the RSV A-based fusion protein, stabilized in the prefusion conformation (preF) in preclinical models. Immunization of naïve cotton rats with preF subunit or p  ...[more]

Similar Datasets

| S-EPMC5929170 | biostudies-literature
| S-EPMC5627276 | biostudies-literature
| S-EPMC4459498 | biostudies-literature
| S-EPMC4672383 | biostudies-literature
| S-EPMC8110191 | biostudies-literature
| S-EPMC11582626 | biostudies-literature
| S-EPMC5857471 | biostudies-literature
| S-EPMC5790933 | biostudies-literature
| S-EPMC10879192 | biostudies-literature
| S-EPMC6506550 | biostudies-literature